FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

421637006: lyophilisat et solvant pour solution injectable (forme pharmaceutique)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
15801000188114 lyophilisat et solvant pour solution injectable fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
3636025015 Lyophilized powder for conventional release solution for injection (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636026019 Lyophilised powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636027011 Lyophilized powder for conventional release solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636028018 Lyophilized powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636029014 Lyophilised powder for solution for injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
660241000241117 lyophilisat et solvant pour solution injectable (forme pharmaceutique) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
lyophilisat et solvant pour solution injectable est un(e) (attribut) Powder for solution for injection true Inferred relationship Some
lyophilisat et solvant pour solution injectable Has dose form administration method (attribute) Inject (administration method) true Inferred relationship Some
lyophilisat et solvant pour solution injectable Has dose form transformation (attribute) Dissolve (transformation) true Inferred relationship Some
lyophilisat et solvant pour solution injectable Has dose form intended site (attribute) Parenteral (intended site) true Inferred relationship Some
lyophilisat et solvant pour solution injectable Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
lyophilisat et solvant pour solution injectable est un(e) (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) false Inferred relationship Some
lyophilisat et solvant pour solution injectable Has basic dose form (attribute) Lyophilized powder (basic dose form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nonacog alfa 250 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely nonacog alfa 1000 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely nonacog alfa 500 international unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely human immunoglobulin G 6 gram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Mitomycin 40 mg lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Octocog alfa 250 international unit lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Octocog alfa 500 international unit lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
OnabotulinumtoxinA 100 unit lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Lurbinectedin 4 mg lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Azacitidine 100 mg lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely remimazolam (as remimazolam besylate) 20 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Clostridium histolyticum collagenase 900 microgram lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Velaglucerase alfa 200unit lyophilized powder for injection solution (product) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Belimumab 400 mg lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Belimumab 120 mg lyophilized powder for solution for injection vial a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Canakinumab 150mg powder for injection solution (product) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some
Product containing precisely abobotulinumtoxinA 500 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) a une forme pharmaceutique (attribut) False lyophilisat et solvant pour solution injectable Inferred relationship Some

This concept is not in any reference sets

Back to Start